DAVID A RAMSAY Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID A RAMSAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID A RAMSAY. DAVID A RAMSAY is Secretary, CFO in HALOZYME THERAPEUTICS INC ($GYHT) and Vice President and CFO in HALOZYME THERAPEUTICS INC ($GYHT) and VP and Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT).
DAVID A RAMSAY in HALOZYME THERAPEUTICS, INC.
Trading Symbol: GYHTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID A RAMSAY: Secretary, CFO, Vice President and CFO, VP and Chief Financial Officer
Holdings: 401,410 shares
Latest Transaction: Jul 27 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID A RAMSAY in HALOZYME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 27 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Option Exercise | M | 0.39 | 30,000 | 11,700 | 464,638 | |
Jul 27 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Buy | M | 0.39 | 30,000 | 11,700 | 401,410 | 371.4 K to 401.4 K (+8.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.99 | 400 | 3,996 | 371,410 | 371.8 K to 371.4 K (-0.11 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.98 | 600 | 5,988 | 371,810 | 372.4 K to 371.8 K (-0.16 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.97 | 1,329 | 13,250 | 372,410 | 373.7 K to 372.4 K (-0.36 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.96 | 400 | 3,984 | 373,739 | 374.1 K to 373.7 K (-0.11 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.95 | 500 | 4,975 | 374,139 | 374.6 K to 374.1 K (-0.13 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.94 | 300 | 2,982 | 374,639 | 374.9 K to 374.6 K (-0.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.93 | 400 | 3,972 | 374,939 | 375.3 K to 374.9 K (-0.11 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.92 | 471 | 4,672 | 375,339 | 375.8 K to 375.3 K (-0.13 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.90 | 300 | 2,970 | 375,810 | 376.1 K to 375.8 K (-0.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.89 | 300 | 2,967 | 376,110 | 376.4 K to 376.1 K (-0.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.86 | 300 | 2,958 | 376,410 | 376.7 K to 376.4 K (-0.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.85 | 200 | 1,970 | 376,710 | 376.9 K to 376.7 K (-0.05 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.84 | 500 | 4,920 | 376,910 | 377.4 K to 376.9 K (-0.13 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.83 | 100 | 983 | 377,410 | 377.5 K to 377.4 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.82 | 100 | 982 | 377,510 | 377.6 K to 377.5 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.81 | 400 | 3,924 | 377,610 | 378 K to 377.6 K (-0.11 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.80 | 2,000 | 19,600 | 378,010 | 380 K to 378 K (-0.53 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.79 | 400 | 3,916 | 380,010 | 380.4 K to 380 K (-0.11 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.78 | 300 | 2,934 | 380,410 | 380.7 K to 380.4 K (-0.08 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.75 | 100 | 975 | 380,710 | 380.8 K to 380.7 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.74 | 100 | 974 | 380,810 | 380.9 K to 380.8 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.02 | 100 | 1,002 | 380,910 | 381 K to 380.9 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.01 | 100 | 1,001 | 381,010 | 381.1 K to 381 K (-0.03 %) |
Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.00 | 300 | 3,000 | 381,110 | 381.4 K to 381.1 K (-0.08 %) |
Jan 14 2005 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Vice President and ... | Option Exercise | M | 0.39 | 100,000 | 39,000 | 384,950 | |
Jan 14 2005 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Vice President and ... | Buy | M | 0.39 | 100,000 | 39,000 | 376,410 | 276.4 K to 376.4 K (+36.18 %) |
Aug 19 2004 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Buy | P | 1.62 | 10,000 | 16,200 | 276,410 | 266.4 K to 276.4 K (+3.75 %) |
Aug 18 2004 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Buy | P | 1.60 | 10,000 | 16,000 | 266,410 | 256.4 K to 266.4 K (+3.90 %) |
Page: 1